X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

AMERICAN JOURNAL OF OPHTHALMOLOGY

期刊標題檢索 AM J OPHTHALMOL 最新評論: Why is the basic not submitting to IOVS? (2024-05-29)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[AMERICAN JOURNAL OF OPHTHALMOLOGY]您好,您是該頁面的第 35630 位訪客。

期刊簡介
期刊名稱AMERICAN JOURNAL OF OPHTHALMOLOGY AMERICAN JOURNAL OF OPHTHALMOLOGY
LetPub Score
7.6
50 ratings
Rate

Reputation
8.8

Influence
6.7

Speed
8.7

期刊簡稱AM J OPHTHALMOL
ISSN0002-9394
E-ISSN1879-1891
h-index171
CiteScore
CiteScoreSJRSNIPCiteScore Rank
9.202.2961.990
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Ophthalmology
Q18 / 137

自引率 (2023-2024)4.90%自引率趨勢
掲載範囲
The American Journal of Ophthalmology is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and visual science specialists describing clinical investigations, clinical observations, and clinically relevant laboratory investigations. Published monthly since 1884, the full text of the American Journal of Ophthalmology and supplementary material are also presented online at www.AJO.com and on ScienceDirect.

The American Journal of Ophthalmology publishes Full-Length Articles, Perspectives, Editorials, Correspondences, Books Reports and Announcements. Brief Reports and Case Reports are no longer published. We recommend submitting Brief Reports and Case Reports to our companion publication, the American Journal of Ophthalmology Case Reports.

Manuscripts are accepted with the understanding that they have not been and will not be published elsewhere substantially in any format, and that there are no ethical problems with the content or data collection. Authors may be requested to produce the data upon which the manuscript is based and to answer expeditiously any questions about the manuscript or its authors.
官方網站http://www.ajo.com/
在線稿件提交https://www.editorialmanager.com/AJO
開放訪問No
出版商Elsevier USA
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1884
每年文章數242每年文章數趨勢
黃金OA百分比22.15%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
OPHTHALMOLOGYSCIEQ110/95
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0002-9394%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-6 Week(s)
來自Elsevier的數據: Average 6 Week(s)
競爭力 *來自作者的數據: Difficult
來自Elsevier的數據: 22%
在線文章發布時間來自Elsevier的數據: Average 8.6 Week(s)
參考鏈接
相關期刊 【AMERICAN JOURNAL OF OPHTHALMOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PROGRESS IN RETINAL AND EYE RESEARCHH-index: 131

    CiteScore: 34.10
    OPHTHALMOLOGYH-index: 217

    CiteScore: 22.30
    Ocular SurfaceH-index: 53

    CiteScore: 11.60
    SURVEY OF OPHTHALMOLOGYH-index: 120

    CiteScore: 10.30
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEH-index: 196

    CiteScore: 6.90
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGYH-index: 67

    CiteScore: 7.60
    BRITISH JOURNAL OF OPHTHALMOLOGYH-index: 137

    CiteScore: 10.30
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIEH-index: 44

    CiteScore: 3.20
    ACTA OPHTHALMOLOGICAH-index: 77

    CiteScore: 7.60
    CURRENT OPINION IN OPHTHALMOLOGYH-index: 79

    CiteScore: 6.80
    學科內最受檢索的期刊 頁面查看次數
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE67583
    OPHTHALMOLOGY43528
    EXPERIMENTAL EYE RESEARCH43311
    BRITISH JOURNAL OF OPHTHALMOLOGY40899
    EYE40889
    CURRENT EYE RESEARCH38477
    CORNEA37591
    ACTA OPHTHALMOLOGICA36966
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY33214
    JOURNAL OF VISION30363
  •  

    AMERICAN JOURNAL OF OPHTHALMOLOGY AMERICAN JOURNAL OF OPHTHALMOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [AMERICAN JOURNAL OF OPHTHALMOLOGY] 的評論撰寫評論
作者: 无妄问风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-29 18:18:12 評論於
Why is the basic not submitting to IOVS?
(0) 讚! | 无妄问风

作者: 樰国


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-31 16:54:28 評論於
 (0) 讚! | 樰国  

作者: 桃花凯凯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-30 08:50:10 評論於
Review Speed: 12.0
Experience Sharing: After revising the submission for 3 weeks, it was resubmitted to the reviewer after 2 weeks. Currently, only one reviewer has accepted the revised manuscript. Nervous
(0) 讚! | 桃花凯凯

作者: 桃花凯凯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-22 16:57:14 評論於
Major renovation does not require external review? Amazing!
(0) 讚! | 桃花凯凯

作者: 火焰寄萍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-27 23:39:06 評論於
It's been a month and there's still no news
(0) 讚! | 火焰寄萍

作者: Wordsworth Tracy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-27 20:15:28 評論於
Review speed: 3.0 | Submission hit rate: 50.0 Focus on research direction: Eye immunity Experience sharing: In progress
(0) 讚! | Wordsworth Tracy

作者: 无击金兰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-19 15:40:25 評論於
Review speed: 3.0 | Submission hit rate: 5.0 Focused research direction: POAG Experience sharing: Waiting for news after submission
(0) 讚! | 无击金兰

作者: 珉林凝莲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-03 21:54:18 評論於
Good
(0) 讚! | 珉林凝莲

作者: 岭南佳文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-12 13:21:49 評論於
Review Speed: 2.0 | Submission Hit Rate: 25.0
Research Focus: Cataract
Experience Sharing: The reviewers are quite professional
(0) 讚! | 岭南佳文

作者: 桃花凯凯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-03 20:18:15 評論於
It's been three months
(0) 讚! | 桃花凯凯

作者: 是你的雁卉呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-03 14:10:06 評論於
I looked at the requirements of this journal, it seems that they do not accept articles on basic research. Also, I checked the recent articles and they are all clinical articles. So, should I submit an article on basic research or not?
(0) 讚! | 是你的雁卉呀

作者: 士恩酱吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-30 19:50:42 評論於
So scary
(0) 讚! | 士恩酱吖

作者: 士恩酱吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-23 18:11:34 評論於
How long until it gets reviewed?
(0) 讚! | 士恩酱吖

作者: 桃花凯凯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-23 12:15:26 評論於
Still under review
(0) 讚! | 桃花凯凯

作者: 士恩酱吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-23 08:01:43 評論於
What happened later?
(0) 讚! | 士恩酱吖

作者: 士恩酱吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-22 17:46:10 評論於
No movement at all. No movement in a week
(0) 讚! | 士恩酱吖

作者: 桃花凯凯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-01 08:16:48 評論於
It's been 2 months with no news, is this normal?
(0) 讚! | 桃花凯凯

作者: 桃花凯凯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-26 19:51:09 評論於
How many reviewers will be invited?
(0) 讚! | 桃花凯凯

作者: 桃花凯凯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-11 16:49:49 評論於
You can choose either OA or traditional subscription model
(0) 讚! | 桃花凯凯

作者: 魂魄诗琪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-23 17:41:44 評論於
Has it been rejected?
(0) 讚! | 魂魄诗琪

作者: 魂魄诗琪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-23 16:34:04 評論於
The situation is the same. It seems like we are going to be rejected as it is not even under review
(0) 讚! | 魂魄诗琪

作者: 魂魄诗琪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-17 18:18:34 評論於
How long until you come back?
(0) 讚! | 魂魄诗琪

作者: 魂魄诗琪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-12 23:11:56 評論於
How long does it usually take for a manuscript to go from "under review by editor" to "under review"?
(0) 讚! | 魂魄诗琪

作者: 风啸奥翔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-01 15:58:26 評論於
Hello, I would like to ask, how long will you be under review by the editor?
(0) 讚! | 风啸奥翔

作者: 锐翰小郎君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-02 22:48:44 評論於
It's with the editor, not submitted yet. I just asked the online customer service
(0) 讚! | 锐翰小郎君

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [AMERICAN JOURNAL OF OPHTHALMOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*